Opioid dependence Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosis of opioid dependence 2. Prescribed opioid substitution treatment (OST) e.g. methadone or buprenorphine 3. Aged 18 years to 65 years 4. Willing and able to provide informed consent 5. Attending an outreach (spoke) clinic for keyworker appointments
Exclusion criteria
Exclusion criteria: 1. Service users who cannot read English AND would require the service of an interpreter to understand a brief oral description of the study 2. Service users who have already entered the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Attendance at appointments measured using electronic care records Feasibility outcomes: 1. Recruitment rate measured using a count of consent forms at follow-up (20 weeks) 2. Retention rate measured using a count of completed questionnaires at follow-up (20 weeks) 3. Acceptability of the study - views and experiences of service users and staff measured using a research interview at follow-up (20 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patient satisfaction measured using the Patient Satisfaction Questionnaire (PSQ) and the Telemedicine Satisfaction Questionnaire (TSQ) (Telemedicine arm only) at the end of the first and second consultations 2. Travel distance measured using electronic care records 3. Addiction changes that occur during treatment measured using the Treatment Outcome Profile (TOP) and urine tests at baseline and at follow-up (20 weeks) 4. Patient and staff evaluation of the process measured using a process evaluation interview at follow-up (20 weeks) 5. Addictions prescriber satisfaction measured using a non-validated questionnaire at follow-up (20 weeks) | — |
Countries
England, United Kingdom